Pocket Otoscope
Pocket Otoscope market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
Global Pneumonia Vaccine Market Insights and Forecast to 2031
1 Study Coverage
1.1 Pneumonia Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumonia Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Pneumonia Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pneumonia Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pneumonia Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pneumonia Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pneumonia Vaccine Sales by Region
2.4.1 Global Pneumonia Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pneumonia Vaccine by Region (2023-2028)
2.5 Global Pneumonia Vaccine Revenue by Region
2.5.1 Global Pneumonia Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pneumonia Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pneumonia Vaccine Sales by Manufacturers
3.1.1 Global Top Pneumonia Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pneumonia Vaccine in 2021
3.2 Global Pneumonia Vaccine Revenue by Manufacturers
3.2.1 Global Pneumonia Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pneumonia Vaccine Revenue in 2021
3.3 Global Pneumonia Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pneumonia Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pneumonia Vaccine Sales by Type
4.1.1 Global Pneumonia Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pneumonia Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pneumonia Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pneumonia Vaccine Revenue by Type
4.2.1 Global Pneumonia Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pneumonia Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pneumonia Vaccine Price by Type
4.3.1 Global Pneumonia Vaccine Price by Type (2017-2022)
4.3.2 Global Pneumonia Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pneumonia Vaccine Sales by Application
5.1.1 Global Pneumonia Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pneumonia Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pneumonia Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pneumonia Vaccine Revenue by Application
5.2.1 Global Pneumonia Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pneumonia Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pneumonia Vaccine Price by Application
5.3.1 Global Pneumonia Vaccine Price by Application (2017-2022)
5.3.2 Global Pneumonia Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pneumonia Vaccine Market Size by Type
6.1.1 North America Pneumonia Vaccine Sales by Type (2017-2028)
6.1.2 North America Pneumonia Vaccine Revenue by Type (2017-2028)
6.2 North America Pneumonia Vaccine Market Size by Application
6.2.1 North America Pneumonia Vaccine Sales by Application (2017-2028)
6.2.2 North America Pneumonia Vaccine Revenue by Application (2017-2028)
6.3 North America Pneumonia Vaccine Market Size by Country
6.3.1 North America Pneumonia Vaccine Sales by Country (2017-2028)
6.3.2 North America Pneumonia Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pneumonia Vaccine Market Size by Type
7.1.1 Europe Pneumonia Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pneumonia Vaccine Revenue by Type (2017-2028)
7.2 Europe Pneumonia Vaccine Market Size by Application
7.2.1 Europe Pneumonia Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pneumonia Vaccine Revenue by Application (2017-2028)
7.3 Europe Pneumonia Vaccine Market Size by Country
7.3.1 Europe Pneumonia Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pneumonia Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumonia Vaccine Market Size by Type
8.1.1 Asia Pacific Pneumonia Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pneumonia Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pneumonia Vaccine Market Size by Application
8.2.1 Asia Pacific Pneumonia Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pneumonia Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pneumonia Vaccine Market Size by Region
8.3.1 Asia Pacific Pneumonia Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pneumonia Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pneumonia Vaccine Market Size by Type
9.1.1 Latin America Pneumonia Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pneumonia Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pneumonia Vaccine Market Size by Application
9.2.1 Latin America Pneumonia Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pneumonia Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pneumonia Vaccine Market Size by Country
9.3.1 Latin America Pneumonia Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pneumonia Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Vaccine Market Size by Type
10.1.1 Middle East and Africa Pneumonia Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pneumonia Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pneumonia Vaccine Market Size by Application
10.2.1 Middle East and Africa Pneumonia Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pneumonia Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pneumonia Vaccine Market Size by Country
10.3.1 Middle East and Africa Pneumonia Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pneumonia Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Overview
11.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc. Recent Developments
11.2 Glaxosmithkline Plc.
11.2.1 Glaxosmithkline Plc. Corporation Information
11.2.2 Glaxosmithkline Plc. Overview
11.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Glaxosmithkline Plc. Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Corporation Information
11.3.2 Merck & Co., Inc. Overview
11.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co., Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 Serum Institute of India Pvt. Ltd.
11.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
11.5.2 Serum Institute of India Pvt. Ltd. Overview
11.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute of India Pvt. Ltd. Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Astellas Pharma Inc.
11.7.1 Astellas Pharma Inc. Corporation Information
11.7.2 Astellas Pharma Inc. Overview
11.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Astellas Pharma Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma Inc. Recent Developments
11.8 Astrazeneca Plc.
11.8.1 Astrazeneca Plc. Corporation Information
11.8.2 Astrazeneca Plc. Overview
11.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Astrazeneca Plc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Astrazeneca Plc. Recent Developments
11.9 CSL Limited
11.9.1 CSL Limited Corporation Information
11.9.2 CSL Limited Overview
11.9.3 CSL Limited Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSL Limited Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSL Limited Recent Developments
11.10 Emergent Biosolutions
11.10.1 Emergent Biosolutions Corporation Information
11.10.2 Emergent Biosolutions Overview
11.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Emergent Biosolutions Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Emergent Biosolutions Recent Developments
11.11 Walvax Biotechnology
11.11.1 Walvax Biotechnology Corporation Information
11.11.2 Walvax Biotechnology Overview
11.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Walvax Biotechnology Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Walvax Biotechnology Recent Developments
11.12 Royal (Wuxi) Bio-Pharmaceutical
11.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
11.12.2 Royal (Wuxi) Bio-Pharmaceutical Overview
11.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
11.13 Zhifei Biologic
11.13.1 Zhifei Biologic Corporation Information
11.13.2 Zhifei Biologic Overview
11.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Zhifei Biologic Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Zhifei Biologic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pneumonia Vaccine Industry Chain Analysis
12.2 Pneumonia Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumonia Vaccine Production Mode & Process
12.4 Pneumonia Vaccine Sales and Marketing
12.4.1 Pneumonia Vaccine Sales Channels
12.4.2 Pneumonia Vaccine Distributors
12.5 Pneumonia Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pneumonia Vaccine Industry Trends
13.2 Pneumonia Vaccine Market Drivers
13.3 Pneumonia Vaccine Market Challenges
13.4 Pneumonia Vaccine Market Restraints
14 Key Findings in The Global Pneumonia Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pneumonia Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Table 3. Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table 4. Major Manufacturers of Other
Table 5. Global Pneumonia Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pneumonia Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 8. Global Pneumonia Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 10. Global Pneumonia Vaccine Sales Market Share by Region (2023-2028)
Table 11. Global Pneumonia Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Pneumonia Vaccine Revenue Market Share by Region (2017-2022)
Table 13. Global Pneumonia Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Pneumonia Vaccine Revenue Market Share by Region (2023-2028)
Table 15. Global Pneumonia Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 16. Global Pneumonia Vaccine Sales Share by Manufacturers (2017-2022)
Table 17. Global Pneumonia Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Pneumonia Vaccine Revenue Share by Manufacturers (2017-2022)
Table 19. Pneumonia Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021)
Table 22. Pneumonia Vaccine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pneumonia Vaccine Product Offered
Table 24. Date of Manufacturers Enter into Pneumonia Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 27. Global Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 28. Global Pneumonia Vaccine Sales Share by Type (2017-2022)
Table 29. Global Pneumonia Vaccine Sales Share by Type (2023-2028)
Table 30. Global Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Pneumonia Vaccine Revenue Share by Type (2017-2022)
Table 33. Global Pneumonia Vaccine Revenue Share by Type (2023-2028)
Table 34. Pneumonia Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 35. Global Pneumonia Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 36. Global Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 37. Global Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 38. Global Pneumonia Vaccine Sales Share by Application (2017-2022)
Table 39. Global Pneumonia Vaccine Sales Share by Application (2023-2028)
Table 40. Global Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Pneumonia Vaccine Revenue Share by Application (2017-2022)
Table 43. Global Pneumonia Vaccine Revenue Share by Application (2023-2028)
Table 44. Pneumonia Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Pneumonia Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 46. North America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 47. North America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 48. North America Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 51. North America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 52. North America Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. North America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 56. North America Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 60. Europe Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 63. Europe Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 64. Europe Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 67. Europe Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 68. Europe Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 71. Asia Pacific Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 72. Asia Pacific Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 75. Asia Pacific Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 76. Asia Pacific Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 79. Asia Pacific Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 80. Asia Pacific Pneumonia Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Pneumonia Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 83. Latin America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 84. Latin America Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 87. Latin America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 88. Latin America Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 91. Latin America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 92. Latin America Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East and Africa Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 96. Middle East and Africa Pneumonia Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Pneumonia Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 99. Middle East and Africa Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 100. Middle East and Africa Pneumonia Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Pneumonia Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 103. Middle East and Africa Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 104. Middle East and Africa Pneumonia Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Pneumonia Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 106. Pfizer Inc. Corporation Information
Table 107. Pfizer Inc. Description and Major Businesses
Table 108. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. Pfizer Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer Inc. Recent Developments
Table 111. Glaxosmithkline Plc. Corporation Information
Table 112. Glaxosmithkline Plc. Description and Major Businesses
Table 113. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. Glaxosmithkline Plc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Glaxosmithkline Plc. Recent Developments
Table 116. Merck & Co., Inc. Corporation Information
Table 117. Merck & Co., Inc. Description and Major Businesses
Table 118. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. Merck & Co., Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Merck & Co., Inc. Recent Developments
Table 121. Sanofi Pasteur Corporation Information
Table 122. Sanofi Pasteur Description and Major Businesses
Table 123. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. Sanofi Pasteur Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sanofi Pasteur Recent Developments
Table 126. Serum Institute of India Pvt. Ltd. Corporation Information
Table 127. Serum Institute of India Pvt. Ltd. Description and Major Businesses
Table 128. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Serum Institute of India Pvt. Ltd. Recent Developments
Table 131. Johnson & Johnson Corporation Information
Table 132. Johnson & Johnson Description and Major Businesses
Table 133. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 134. Johnson & Johnson Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Johnson & Johnson Recent Developments
Table 136. Astellas Pharma Inc. Corporation Information
Table 137. Astellas Pharma Inc. Description and Major Businesses
Table 138. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 139. Astellas Pharma Inc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Astellas Pharma Inc. Recent Developments
Table 141. Astrazeneca Plc. Corporation Information
Table 142. Astrazeneca Plc. Description and Major Businesses
Table 143. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 144. Astrazeneca Plc. Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Astrazeneca Plc. Recent Developments
Table 146. CSL Limited Corporation Information
Table 147. CSL Limited Description and Major Businesses
Table 148. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 149. CSL Limited Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. CSL Limited Recent Developments
Table 151. Emergent Biosolutions Corporation Information
Table 152. Emergent Biosolutions Description and Major Businesses
Table 153. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 154. Emergent Biosolutions Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Emergent Biosolutions Recent Developments
Table 156. Walvax Biotechnology Corporation Information
Table 157. Walvax Biotechnology Description and Major Businesses
Table 158. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 159. Walvax Biotechnology Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Walvax Biotechnology Recent Developments
Table 161. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 162. Royal (Wuxi) Bio-Pharmaceutical Description and Major Businesses
Table 163. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 164. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 166. Zhifei Biologic Corporation Information
Table 167. Zhifei Biologic Description and Major Businesses
Table 168. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 169. Zhifei Biologic Pneumonia Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Zhifei Biologic Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Pneumonia Vaccine Distributors List
Table 174. Pneumonia Vaccine Customers List
Table 175. Pneumonia Vaccine Market Trends
Table 176. Pneumonia Vaccine Market Drivers
Table 177. Pneumonia Vaccine Market Challenges
Table 178. Pneumonia Vaccine Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 3. Global Pneumonia Vaccine Market Share by Type in 2021 & 2028
Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pneumonia Vaccine Market Share by Application in 2021 & 2028
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Sepsis
Figure 10. Pneumonia Vaccine Report Years Considered
Figure 11. Global Pneumonia Vaccine Sales 2017-2028 (K Doses)
Figure 12. Global Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pneumonia Vaccine Revenue 2017-2028 (US$ Million)
Figure 14. Global Pneumonia Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pneumonia Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Pneumonia Vaccine Sales Market Share by Region (2023-2028)
Figure 17. North America Pneumonia Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Pneumonia Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pneumonia Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Pneumonia Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pneumonia Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Pneumonia Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pneumonia Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Pneumonia Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pneumonia Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Pneumonia Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pneumonia Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pneumonia Vaccine in the World: Market Share by Pneumonia Vaccine Revenue in 2021
Figure 29. Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. North America Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 35. North America Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. North America Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Pneumonia Vaccine Sales Share by Country (2017-2028)
Figure 39. North America Pneumonia Vaccine Revenue Share by Country (2017-2028)
Figure 40. U.S. Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pneumonia Vaccine Sales Share by Country (2017-2028)
Figure 47. Europe Pneumonia Vaccine Revenue Share by Country (2017-2028)
Figure 48. Germany Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. France Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pneumonia Vaccine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pneumonia Vaccine Revenue Share by Region (2017-2028)
Figure 59. China Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. India Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Latin America Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Pneumonia Vaccine Sales Share by Country (2017-2028)
Figure 74. Latin America Pneumonia Vaccine Revenue Share by Country (2017-2028)
Figure 75. Mexico Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Pneumonia Vaccine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Pneumonia Vaccine Revenue Share by Country (2017-2028)
Figure 84. Turkey Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Pneumonia Vaccine Revenue (2017-2028) & (US$ Million)
Figure 87. Pneumonia Vaccine Value Chain
Figure 88. Pneumonia Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Inc. Glaxosmithkline Plc. Merck & Co., Inc. Sanofi Pasteur Serum Institute of India Pvt. Ltd. Johnson & Johnson Astellas Pharma Inc. Astrazeneca Plc. CSL Limited Emergent Biosolutions Walvax Biotechnology Royal (Wuxi) Bio-Pharmaceutical Zhifei Biologic